结论PR 3、MPO抗体作为系统性血管炎的一种敏感标记抗体，有利于该疾病的早期治疗。
Conclusion as sensitive markers of systemic vasculitis, anti-PR3 and anti-MPO antibody may be useful for diagnosis and early treatment.
但是，对激素静脉冲击疗法治疗系统性血管炎的最佳剂量和治疗频率还没有作过有对照组的临床研究。
However, the optimal dose and frequency of administration of IV GC have not been studied in a controlled fashion for systemic vasculitis.
边缘性角膜溃疡可能是系统性血管炎的首发表现，也可能预示着某些风湿病进入了严重的血管炎阶段。
PUK may be the first manifestation of systemic vasculitis or only indicate a certain stage of serious vasculitis.
探究抗蛋白酶3（PR3）抗体、抗髓过氧化物酶（MPO）抗体在系统性血管炎患者中检测的临床意义。
To study the clinical significance of anti-PR3 and anti-MPO s detection in systemic vasculitis.
与静脉应用甲基强的松龙相比，血浆置换使发病时伴有肾衰的ANCA相关性系统性血管炎患者肾脏恢复比例增加。
Plasma exchange increased the rate of renal recovery in ANCA-associated systemic vasculitis that presented with renal failure when compared with intravenous methylprednisolone.
与静脉应用甲基强的松龙相比，血浆置换使发病时伴有肾衰的ANCA相关性系统性血管炎患者肾脏恢复比例增加。
Plasma exchange increased the rate of renal recovery in ANCA-associated systemic vasculitis that presented with renal failure when compared with intravenous methylprednisolone.
应用推荐